May 23 – 26, 2018 in Lisbon, Portugal. Lisboa
![]() |
![]() |
![]() |
![]() |
eP-1 | Total Laparoscopic Living Donor Right Hepatectomy for Modified Extended Right Graft | Jai Young Cho | ![]() |
![]() |
|||
eP-2 | Totally laparoscopic right hepatectomy for adult living donor liver transplantation with unfavored anatomy | Young Jae Chung | ![]() |
![]() |
|||
eP-4 | Budd Chiari syndrome with caval thrombosis: Technical strategies for successful left lobe or right lobe living donor liver transplantation | Mettu Reddy | ![]() |
![]() |
|||
P-004 | Treating Vasoplegic Syndrome in Liver Transplantation with Hydroxocobalamin: A Case Series | Sher-Lu Pai | ![]() |
![]() |
|||
eP-5 | Laparoscopic donor hepatectomy - The way forward : first case report from India GEM Hospital and Research Centre , Coimbatore, India | Anand Natesan | ![]() |
![]() |
|||
P-5 | Proposal of Prognostic Survival Models Before and After Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients | STEFANO DI SANDRO | ![]() |
![]() |
|||
eP-6 | A simple back benching test to assess the implantability of Inferior Hepatic veins in Right lobe grafts. | Vachan Hukkeri | ![]() |
![]() |
|||
eP-7 | Ex-Situ Resection with Liver Auto-Transplantation for Locally Advanced Cholangiocarcinoma Causing Secondary Budd-Chiari Syndrome: An Occams Razor? | Ashwin Rammohan | ![]() |
![]() |
|||
eP-8 | Useful technical tips in pure laparoscopic donor right hepatectomy | Kyung-Suk Suh | ![]() |
![]() |
|||
P-008 | Multiple graft hepatic arteries in right lobe live donor liver transplantation: outcome with a policy of ive re-vascularization | sujeet saha | ![]() |
![]() |
|||
P-009 | Split liver transplantation reduces mortality on waiting list with high rate of biliary complications but no different post-transplant mortality: 111 consecutive cases | Marek Kysela | ![]() |
![]() |
|||
eP-9 | Pure 3d laparoscopic donor right hemihepatectomy in the case with anatomic variation of portal vein and bile duct | Kwang-Woong Lee | ![]() |
![]() |
|||
eP-11 | Living Donor Liver Transplantation for Leiomyosarcoma of Inferior Vena Cava(IVC) causing Secondary Budd Chiari Syndrome | Palaniappan Kumar | ![]() |
![]() |
|||
eP-12 | Caudate lobectomy combined with portal vein reconstruction using collateral vein for advanced aggressive fibromatosis at the hepatic hilum | Xiangcheng Li | ![]() |
![]() |
|||
eP-13 | Portomesenteric shunt for liver transplantation and complete portal vein thrombosis | Xiangcheng Li | ![]() |
![]() |
|||
P-13 | The immunosuppression strategy after liver transplant for acute liver failure | Deng Feiwen | ![]() |
![]() |
|||
P-014 | Alcoholic Cirrhosis and Psychic Symptoms of Patients Listed for a Liver Transplantation: Correlation and Outcomes | giovanna mazzarone | ![]() |
![]() |
|||
eP-14 | Living Donor Liver Transplantation for Abernethy Malformtion and Severe Hepato-Pulmonary Syndrome | Palaniappan Kumar | ![]() |
![]() |
|||
eP-15 | Totally laparoscopic living donor right hepatectomy in bile duct anomalies | Heon Tak Ha | ![]() |
![]() |
|||
P-015 | Interesting Biodata of Cryptogenic Cirrhosis- A Single Centre Experience | Chandan Kumar Kedarisetty | ![]() |
![]() |
|||
eP-16 | Coronary vein to portal vein anastomosis for the recipient with small portal vein and large coronary vein in living donor liver transplantation | Koji Natsuda | ![]() |
![]() |
|||
P-16 | The Impact of Rotational Thromboelastometry on Resource Utilization Following Liver Transplantation | Mauro Enrique Tun Abraham | ![]() |
![]() |
|||
eP-17 | Hybrid 3D Laparascopic Right Lobe Donor Hepatectomy - First Series From South Asia | Thiagarajan Srinivasan | ![]() |
![]() |
|||
eP-18 | Peeling off technique in liver transplantation in patients with stents after Tips | Xiangcheng Li | ![]() |
![]() |
|||
P-18 | No evidence for a role of storage duration of non-fresh red blood cells on mortality following living donor liver transplantation | Kagnha Jung | ![]() |
![]() |
|||
eP-19 | Orthotopic piggyback liver transplantation by side-to-side caval anastomosis | Xiaofeng Wu | ![]() |
![]() |
|||
P-19 | Antibiotic Prophylaxis for Gastrointestinal Endoscopy-Associated Sepsis in Cirrhotic Patients Waiting for Liver Transplantation | Yi-Chia Chan | ![]() |
![]() |
|||
eP-20 | Liver transplantation for advanced hepatocellular carcinoma combined with portal vein tumor thrombus | Ke Wang | ![]() |
![]() |
|||
P-20 | Incidence, and impact of hyperfibrinolysis during liver transplantation in a multicenter study | annabel blasi | ![]() |
![]() |
|||
P-21 | The predictive value of fibrinolytic activity phenotypes during liver transplantation. | Evgeniia Kraisvetnaia | ![]() |
![]() |
|||
P-022 | Postoperative coagulation profile in 50 living liver donors (thromboelastogram vs conventional tests): implications on epidural analgesia | G V PREMKUMAR | ![]() |
![]() |
|||
P-23 | Assessment of the congruence between the TEG5000 and the TEG6S in Liver Transplant Patients: a validation study | robson jacqueline | ![]() |
![]() |
|||
LBP-24 | Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus in the European Liver Transplant Registry (ELTR): Long-term Follow-up, Extension Study | Vincent KARAM | ![]() |
![]() |
|||
P-024 | Coronary artery calcium score as a screening test for cardiac evaluation in liver transplant recipients | Ellango Appuswamy | ![]() |
![]() |
|||
LBP-025 | Changes in Transfusion Practice with Introduction of Rotational Thromboelastometry (ROTEM) in Deceased Donor Liver Transplantation (DDLT) | Eva Hosrtas | ![]() |
![]() |
|||
P-25 | Major Perioperative Thrombotic Events in Liver Transplant Recipients | Christine Nguyen-Buckley | ![]() |
![]() |
|||
P-26 | Universal use of prestorage leukoreduction did not decrease death risk after living donor liver transplantation | Suyong Jeon | ![]() |
![]() |
|||
P-027 | Insulin therapy for postreperfusion hyperglycemia during liver transplantation: A retrospective cohort study | Seong Mi Yang | ![]() |
![]() |
|||
LBP-28 | Impact of Middle Hepatic Vein Reconstruction on Living Donor Liver Transplantation Using Right Hemiliver Graft | Hong Sung Yeon | ![]() |
![]() |
|||
P-28 | Osmotic demyelination syndrome following hyponatremia-oriented management in liver transplantation: in a single center twenty year experience | Suyong Jeon | ![]() |
![]() |
|||
P-33 | The knockout of aldose reductase accelerates liver regeneration through AMPK/SIRT1/ PGC-1a network | Chang Xian Li | ![]() |
![]() |
|||
LBP-034 | Orthotopic Liver Transplantation for Mixed-cellularity Hepatocarcinoma-intrahepatic Cholangiocarcinoma: A Single Centre Experience | Mihnea Ioan Ionescu | ![]() |
![]() |
|||
LBP-035 | The effects of diastolic dysfunction (DD) defined by the electrocardiographic measures of ventricular repolarization (EMVR) on outcomes after deceased donor liver transplantation (ddLT) | eva hortas | ![]() |
![]() |
|||
P-035 | CCAAT-enhancer-binding protein homologous protein (CHOP) promotes liver ischemia and reperfusion injury by inhibiting beclin-1-mediated autophagy in hepatocytes. | Haoming Zhou | ![]() |
![]() |
|||
LBP-38 | Long-term Analysis for Biliary Complications after Duct-to-Duct Biliary Reconstruction in Living Donor Liver Transplantation: Risk Factors and Impact of External Biliary Stent | Hong Sung Yeon | ![]() |
![]() |
|||
LBP-039 | Donation after Circulatory Death Type 2 Liver Transplantation in a Large Referral Centre in the United Kingdom: A Feasibility Study | Mihnea Ioan Ionescu | ![]() |
![]() |
|||
LBP-40 | Aetiology of Delirium Post Liver Transplant and the Effect on Inpatient Length of Stay | Oliver Tavabie | ![]() |
![]() |
|||
LBP-041 | Perioperative Characteristics of Liver Transplantation for Isolated Methylmalonic Acidemia and Management Experience | Jiang Yizhou | ![]() |
![]() |
|||
LBP-044 | The effect of donor-derived infections on liver transplantation recipents | Wei Song | ![]() |
![]() |
|||
LBP-046 | Comparison of Different Components of Rotational Thromboelastometry (Rotem) in Relation to Consumption of Fresh Frozen Plasma (FFP) in Deceased Donor Liver Transplantation (DDLT) | eva hortas | ![]() |
![]() |
|||
LBP-047 | The Potential Utility of a Hemoadsobtion Column (CytoSorb) in Patients with Acute Liver Failure | Mihai Popescu | ![]() |
![]() |
|||
P-048 | Experimental evaluation of liver regeneration patterns in small-for-size livers | Ji-Hua Shi | ![]() |
![]() |
|||
LBP-048 | Orthotopic Liver Transplant and Post-operative Renal Replacement Therapy: A 5 Year Review | Siobhan McGuinness | ![]() |
![]() |
|||
LBP-49 | Bile Duct Anatomy of Caudate Lobe in Living Liver Donor Evaluated by Gd-EOB-DTPA-enhanced 3D T1-weighted MR Cholangiography | Heon Ju Kwon | ![]() |
![]() |
|||
LBP-50 | Aging Aggravates Hepatic Ischemia Reperfusion Injury by Impairing Mitophagy with Involvement of EIF2a-Parkin Pathway | Yang Li | ![]() |
![]() |
|||
LBP-051 | Higher risk of post-transplant graft failure in male recipients of female donor grafts may be not due to anastomotic size disparity | Chung Young Jae | ![]() |
![]() |
|||
LBP-52 | Liver Transplantation in Kazakhstan: Single Center Experience of First 100 Cases | Zhassulan Baimakhanov | ![]() |
![]() |
|||
LBP-53 | Treatment of Anastomotic Bilio-biliary Stricture after Adult Liver Transplantation: A Retrospective Study over 25 Years in a Single Center | Jerome Dumortier | ![]() |
![]() |
|||
P-57 | THE IMPACT OF THE HYPOTHALAMUS-PITUITARY-ADRENAL AXIS IN BRAIN-DEAD DONORS IN STEATOTIC LIVER TRANSPLANTATION | Elsa Negrete | ![]() |
![]() |
|||
LBP-057 | Case Series of Intraoperative Continuous Replacement Renal Therapy through the Venovenous Bypass Circuit during Orthotopic Liver Transplant, a Novel Approach | Christine Myo | ![]() |
![]() |
|||
P-058 | Cost Effectiveness of Immunosuppression Withdrawal after Liver Transplantation | Marco Pellicciaro | ![]() |
![]() |
|||
LBP-59 | Does the Old Graft Benefit from a Young Recipient - Influence of Donor Recipient Age Discrepancy (DRAD) in Liver Transplantation | Yasuhito Iwao | ![]() |
![]() |
|||
P-60 | Rapamycin induces a tolerogenic phenotype in dendritic cells in vitro | Geraldine Dahlqvist | ![]() |
![]() |
|||
LBP-060 | The Percentage-change of Graft-derived Cell-free DNA in Ornithine Transcarbamylase Deficiency Patient after Living-donor Liver Transplantation | Hoi Ioi Ng | ![]() |
![]() |
|||
LBP-061 | The Value of Routine Cholangiography on the Diagnosis of Biliary Tract Complications after Liver Transplantation | ELIANO BONACCORSI-RIANI | ![]() |
![]() |
|||
P-61 | Galectin-1 induced donor derived dendritic cells in combination with apoptotic lymphocytes promote immune tolerance of liver transplantation in rat | Lin Zhou | ![]() |
![]() |
|||
LBP-63 | Splenic Artery Transposition for the Repair of a Mycotic Pseudoaneurysm of the Hepatic Artery after Liver Transplantation A Case Report | Eduardo Briceńo | ![]() |
![]() |
|||
P-063 | Reduction in Circulating CD19CD24CD27 Regulatory B Cell Frequency Predicts Acute Rejection in Liver Transplant Patients. | Haoming Zhou | ![]() |
![]() |
|||
LBP-064 | Analysis of 20 Year Survival after Liver Transplantation in Children | Rebeca Sanabria-Mateos | ![]() |
![]() |
|||
P-066 | Intramuscular Hepatitis B inmune globulin use in the prophylaxis of hepatitis B virus recurrence after liver trasplantation. Single center experience. | Alba Cachero | ![]() |
![]() |
|||
P-067 | Single Center Experience in HCC Recurrence with DAA Treatment in Liver Transplant Recipients | Paria Mahboub | ![]() |
![]() |
|||
LBP-67 | Salvage Therapies for Complicated ABO Incompatible Living Donor Liver Transplantation: A Case Report for Patient with End Stage Liver Cirrhosis and Chronic Kidney Disease | Sheng-Chih Kuo | ![]() |
![]() |
|||
LBP-068 | Complications after Liver Transplantation for Citrullinemia Type 1: The Role of Arginine and Nitric Oxide | Carolin Lemoine | ![]() |
![]() |
|||
LBP-69 | Bending-over Backwards for a Severe Technical Challenge: 4th Split Liver Transplant (SLTx) with Reno-portal Anastomosis for Recurrent PVT in a Situs Inversus (SI) Pediatric Patient | Nadiane Paderno | ![]() |
![]() |
|||
LBP-70 | Aging in Liver Transplant Waiting List: Disparity between Candidates and Grafts | NADIA ILEANA DACIUK | ![]() |
![]() |
|||
LBP-071 | Early Experience of an Emerging Liver Transplant Program in Southeast Asia | Vanessa de Villa | ![]() |
![]() |
|||
LBP-072 | EBV-positive Posttransplant Lymphoproliferative Disorder in a 1-year Old Patient with Severe Co-morbidities after Liver Transplantation | Jingyi Liu | ![]() |
![]() |
|||
P-72 | The Effect of End-Ischaemic Normothermic Machine Perfusion versus Static Cold Storage on Donor Hepatic Artery Endothelial Integrity: A Preliminary Study | Joseph Attard | ![]() |
![]() |
|||
LBP-073 | Biliary disease caused by cytomegalovirus infection in patients with biliary complications after liver transplantation: extension of our previous knowledge | Jian-Rui Zhang | ![]() |
![]() |
|||
P-73 | Viability outcomes for donor livers discarded due to steatosis following extra-corporeal machine perfusion of the liver | Yuri Boteon | ![]() |
![]() |
|||
LBP-075 | Outcome of Children with Extrahepatic Biliary Atresia who Underwent Liver Transplantation without Kasai-Portoenterostomy | Sergio Assia-Zamora | ![]() |
![]() |
|||
P-075 | Molecular Adsorbent Recirculating System Support Followed by Liver Transplantation for Multiorgan Failure from Exertional Heatstroke | Hashem Akbar | ![]() |
![]() |
|||
LBP-76 | Comparative Analysis of Using Frame and Frameless Drainage for Duct-to-Duct Anastomosis during Living Donor Liver Transplantation | Maxat Doskhanov | ![]() |
![]() |
|||
P-076 | Reasons for donor rejection prior to living donor liver transplantation. | sujeet saha | ![]() |
![]() |
|||
LBP-078 | Patency of Middle Hepatic Vein Tributaries and Right Inferior Hepatic Vein Reconstructed with Different Sized PTFE Vascular Graft in Right Lobe Living Donor Liver Transplantation | Sami Akbulut | ![]() |
![]() |
|||
P-78 | Frailty and reduced gait speed are associated to decreased survival in cirrhotic patients | Carlos Benítez | ![]() |
![]() |
|||
LBP-079 | Do initial coagulation tests reflect blood product consumption during deceased donor liver transplantation (DDLT)? | Eva Hortas | ![]() |
![]() |
|||
P-80 | Expedited Evaluation for Liver Transplantation: A Critical Look at Processes and Outcomes | Hillary Braun | ![]() |
![]() |
|||
LBP-080 | Risk Factors for Biliary Complications after Liver Transplantation, in the Absence of Arterial Complications | Agnaldo Soares Lima | ![]() |
![]() |
|||
LBP-081 | Successful Management of de Novo Acute Hepatitis B with Entecavir in a Patient Underwent Living Donor Liver Transplantation | Sami Akbulut | ![]() |
![]() |
|||
P-081 | Preoperative assessment of muscle mass using computerized tomography scans to predict outcomes following orthotopic liver transplantation | Thomas Resch | ![]() |
![]() |
|||
LBP-84 | Case of Liver Transplantation in an Infant with Biliary Atresia Associated with Situs Viscerum Inversus and other Congenital Anomalies | Yordanka Uzunova | ![]() |
![]() |
|||
LBP-085 | Erector Spinae Plane Catheters for Analgesia Post Orthotopic Liver Transplantation | Siobhan McGuinness | ![]() |
![]() |
|||
P-86 | Marijuana in Liver Transplant Recipients | Pablo Serrano Rodriguez | ![]() |
![]() |
|||
LBP-087 | First Use of Cytosorb during Living Related Liver Transplantation in a Patient with Acute Liver Failure due to Wilsons Disease | Dana Tomescu | ![]() |
![]() |
|||
P-87 | Time trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades | Prof. dr. Herold Metselaar | ![]() |
![]() |
|||
P-89 | Outcomes of liver transplantation with clonorchis-infected grafts: 5 cases and review of literature | Miu Yee Chan | ![]() |
![]() |
|||
LBP-089 | Clinical Characteristics of Liver Transplantation for Glycogen Storage Disease | Xiaoying Li | ![]() |
![]() |
|||
LBP-90 | Portal Vein Arterialization (PVA) as a Salvage procedure in a patient with Portal Vein Thrombosis (PVT) grade IV | camilla cesar | ![]() |
![]() |
|||
LBP-91 | Unusual Indications of Liver Transplantation | Andres Troncoso | ![]() |
![]() |
|||
P-093 | Incidental mixed hepatocellular and cholangiocarcinoma in patients who underwent liver transplantation - can we avoid a surprise? | Ming Yuan Tan | ![]() |
![]() |
|||
P-094 | Retrograde extrabiliary cholangioplasty for advanced bile leaks after living donor liver transplantation | YI-TING YEH | ![]() |
![]() |
|||
LBP-094 | Comparison of Standard and Modified Standart Organ Procurement Technique for Deceased Donors | Sami Akbulut | ![]() |
![]() |
|||
LBP-96 | Significant Efficacy of Apatinib in a HCC Patient with Lung Metastasis after Liver Transplantation: A Case Report | wang guoying | ![]() |
![]() |
|||
P-97 | Anatomical Variations of the Right Hepatic Duct | Samuel Obiekwe | ![]() |
![]() |
|||
LBP-097 | Is There Any Relationship between Clinical Parameters and Histopathologic Features of Gallbladder Specimens Obtained Living Liver Donors? | Sami Akbulut | ![]() |
![]() |
|||
LBP-098 | The Quick Portocaval Shunt A Prophylaxis against Splanchnic Hemorrhage during Orthotopic Liver Transplantation | Ryan Chadha | ![]() |
![]() |
|||
P-099 | Three-dimensional printing with biotexture modeling assisted donor left hepatectomy | Sonal Asthana | ![]() |
![]() |
|||
LBP-99 | Impact of Positive Donor-specific HLA Antibodies (DSA) Crossmatch on Graft Survival in ABO Incompatible Liver-kidney Transplantation: A Case Report | Ping-Yi Lin | ![]() |
![]() |
|||
P-100 | Sarcopenia in Cirrhosis Before Living Donor Liver Transplantation | Sencan Acar | ![]() |
![]() |
|||
LBP-101 | Ex Situ in vivo Resection of Leiomyosarcoma of the Inferior Vena Cava: An Anaesthetic Challenge | NAIR SHRIJIT | ![]() |
![]() |
|||
P-103 | Antegrade arterial and portal flushing versus portal flushing only for right lobe live donor liver transplantation - A Randomized control trial | Rommel Sandhyav | ![]() |
![]() |
|||
LBP-106 | Non-traditional Use of Transesophageal Echocardiography to Evaluate Hepatic Vasculature in Orthotopic Liver Transplantation: Review of Literature and Case Report | Narjeet Khurmi | ![]() |
![]() |
|||
LBP-107 | Early Death in Adults after Orthotopic Liver Transplantation at Department of General, Transplant and Liver Surgery in Warsaw | Malgorzata Nowosad | ![]() |
![]() |
|||
LBP-108 | How Should We Approach to Incidentally Detected Neuroendocrine Tumor during Living Donor Hepatectomy? | Sami Akbulut | ![]() |
![]() |
|||
LBP-109 | Case Report: Difficult Vascular Access in a Paediatric Third Re-do Liver Transplant Patient | Sanjay Agrawal | ![]() |
![]() |
|||
LBP-111 | Orthotopic Liver Transplantation for a Pediatric Patient with Very Severe Hepatopulmonary Syndrome | Cong-Huan Shen | ![]() |
![]() |
|||
P-114 | Excellent outcomes after portal flow modulation in living donor liver transplantation | Tiffany Wong | ![]() |
![]() |
|||
P-115 | Better donor outcome following left lobe hepatectomy in adult-to-adult living donor liver transplant | Kelvin K. Ng | ![]() |
![]() |
|||
P-116 | Ex-vivo reconstruction of Right lobe liver graft with a Dacron Caval interposition graft for Budd-Chiari Syndrome without Veno-veno bypass | Swaminathan Sambandam | ![]() |
![]() |
|||
P-120 | Endoscopic treatment of biliary complications after pediatric liver transplantation in a high volume transplant center in Turkey. | MUHSIN MURAT MUHIP HARPUTLUOGLU | ![]() |
![]() |
|||
P-123 | Pediatric Living Donor Liver Transplantation with Large-for-Size Left Lateral Segment Grafts | Nicolas Goldaracena | ![]() |
![]() |
|||
P-130 | Early and Late Hepatic artery thrombosis after liver transplantation: Single-centre experience | Yogesh Puri | ![]() |
![]() |
|||
P-132 | Long term follow-up of HEREDITARY HAEMORRHAGIC TELANGIECTASIA patients who UNDERWENT LIVER TRANSPLANTATION for SEVERE LIVER INVOLVEMENT | boillot olivier | ![]() |
![]() |
|||
P-134 | Selection and outcomes of Living Donor Liver Grafts for recipients weighing 6 Kg or less- A single center experience | Anisha tiwari | ![]() |
![]() |
|||
P-135 | Compared with Rifampicin, the Use of Rifabutin in Adult Living Donor Liver Transplant Recipients with Tuberculosis Does Not Decrease the Incidence of Graft Rejection | Noruel Gerard Salvador | ![]() |
![]() |
|||
P-136 | Spokes on Hub Model with Old horses for New Courses Validation of A Durable Template for Setting up Safe Deceased-Donor Transplant Units in Developing Countries | Ashwin Rammohan | ![]() |
![]() |
|||
P-138 | Comparison of incidence and outcomes in Early Allograft Dysfunction among LD, DCD and DBD grafts. | Sreelakshmi Kotha | ![]() |
![]() |
|||
P-139 | Results of Full-Left-and-Full-Right Split Liver Grafts | Anne-Baue van Dijk | ![]() |
![]() |
|||
P-141 | Excellent outcomes after liver transplantation in patients with chronic portal vein thrombosis: role of extensive thrombectomy and back-up multivisceral transplantation | Chandrashekhar Kubal | ![]() |
![]() |
|||
P-142 | Living donor liver transplantation for moderate to very severe hepatopulmonary syndrome: an experience of 24 patients | Sanjiv Saigal | ![]() |
![]() |
|||
P-143 | Liver Transplantation in patients with Acute-on-Chronic-Liver-Failure and Long Term Outcome | Antonella Putignano | ![]() |
![]() |
|||
P-144 | Piggyback or cava replacement which technique is protective against acute kidney injury after transplantation? | Jeannette Widmer | ![]() |
![]() |
|||
P-145 | Role of hypercoagulability and DIC in thrombotic and hemorrhagic complications in visceral transplantation: a TEG-guided analysis and management algorithm | Yehuda Raveh | ![]() |
![]() |
|||
P-147 | Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients? | Ilker Turan | ![]() |
![]() |
|||
P-150 | Toll-Like Receptor 9 -1486C/T Genetic Polymorphism is Associated with Hepatocarcinoma Recurrence after Liver Transplantation | Sara de la Fuente | ![]() |
![]() |
|||
P-151 | Early Clostridium dif?cile Infection and Risk Factors Analysis in Liver Transplant Adult Recipients: A Single Center Experience | Shih min Yin | ![]() |
![]() |
|||
P-153 | Role of Procalcitonin in Predicting New Onset Sepsis and in Guiding Immunosuppressant Therapy in Early Post Liver Transplantation Period. | Rather Shiraz | ![]() |
![]() |
|||
P-156 | Enhanced Recovery Program: an Effective Approach for Post-Operative Care in Liver Transplanted Patients. | Antonio Romano | ![]() |
![]() |
|||
P-158 | New onset hepatic steatosis after liver transplant is often seen but does not impact post-transplant survival: A single center experience | David Victor | ![]() |
![]() |
|||
P-159 | Comprehensive complication index measure at moment of post-liver transplant discharge well predicts long-term survival | FABIO MELANDRO | ![]() |
![]() |
|||
P-160 | Factors Associated with the Development of Chronic Kidney Disease after Liver Transplantation | Marit Kalisvaart | ![]() |
![]() |
|||
P-161 | IS RETREAT SCORE APPLICABLE TO LIVING DONOR LIVER TRANSPLANT PATIENTS WITH HCC | muhammad osama tariq butt | ![]() |
![]() |
|||
P-162 | Dunbar syndrome in liver transplantation: results of a single center matched-pair analysis and a European survey study | Zoltan Czigany | ![]() |
![]() |
|||
P-165 | The Success of Kaffes Stent Insertions for Post Liver Transplant Anastomotic Strictures | Ben Warner | ![]() |
![]() |
|||
P-167 | Saphenous vein conduits for hepatic arterial reconstruction in living donor liver transplantation | Abu Bakar Hafeez Bhatti | ![]() |
![]() |
|||
P-170 | The influence of donor metabolic factors on long-term liver graft survival | Marjolein van Reeven | ![]() |
![]() |
|||
P-171 | Livers from donation after circulatory death donors can be safely used for retransplantation | Marjolein van Reeven | ![]() |
![]() |
|||
P-175 | Three months outcome analysis after delayed abdominal fascial closure in adult liver transplantation. | Ivan Vella | ![]() |
![]() |
|||
P-178 | Incidence, significance and outcome of Ischemia-Reperfusion Injury in 1113 living donor liver transplants | Amey Sonavane | ![]() |
![]() |
|||
P-181 | Analysis of the predictive ability for graft loss and mortality of two criteria for early allograft dysfunction after liver transplantation. | Yiliam Fundora-Suarez | ![]() |
![]() |
|||
P-182 | The first fifteen days of calcineurin inhibitors exposure do not predict post-transplant malignant outcomes | Tommaso Di Maira | ![]() |
![]() |
|||
P-183 | Frequency of thyroid dysfunction in patients with diabetes mellitus before and after liver transplantation. | Ilka Boin | ![]() |
![]() |
|||
P-184 | Excellent outcomes for transplantation for HCC beyond Milan Criteria: a single center experience. | David Victor | ![]() |
![]() |
|||
P-186 | Impact of the Material on the Patency of Reconstructed Middle Hepatic Vein in Living Donor Liver Transplantation Using the Right Liver. | Soo Ho Lee | ![]() |
![]() |
|||
P-187 | Validity of Doppler Ultrasound as Long Term Follow Up in Liver Transplant Recipients | Pablo Serrano Rodriguez | ![]() |
![]() |
|||
P-188 | Donor specific anti-HLA antibodies are not associated with non-anastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation | Bart van Hoek | ![]() |
![]() |
|||
P-190 | Routine Flow Measurements and Aggressive Inflow Modulation Prevents Flow-Related Complications in Both Deceased and Living Donor Liver Transplantation Recipients | Yee Lee Cheah | ![]() |
![]() |
|||
P-191 | Preformed Donor-Specific Antibodies Do not Affect the One-Year Allograft Survival in Living Donor Liver Transplantation | Hyeyoung Kim | ![]() |
![]() |
|||
P-192 | Midodrine conveys increased risk for waitlist mortality in liver transplant patients | Jennifer Kalil | ![]() |
![]() |
|||
P-193 | Outcomes Retrospective Comparative Study About Interferon-Based versus Direct-Acting Antiviral (DAA)-Based Preemptive Treatment of HCV After Living Donor Liver Transplantation | Jae Hyun Kwon | ![]() |
![]() |
|||
P-200 | Fecal microbiome as a potential biomarker for liver transplantation evolution. An European single center experience. | CRISTINA DOPAZO | ![]() |
![]() |
|||
P-202 | A New Approach to Overcoming Biliary Complications after Laparoscopic Living Donor Liver Transplantation | Ji Soo Lee | ![]() |
![]() |
|||
P-203 | Living donor liver transplantation provided an excellent outcome for acute on chronic failure patients | Chih-Che Lin | ![]() |
![]() |
|||
P-206 | Significant Improvement of MR Cholangiopancreatography Image Quality with Oral Administration of Effervescent Agent | Heon Ju Kwon | ![]() |
![]() |
|||
P-208 | Study of anatomical variations of hepatic vasculature using Multidetector Computer Tomography (MDCT) angiography in 500 patients | ABEER SYED ANWAR | ![]() |
![]() |
|||
P-211 | Hepatic artery Doppler flow changes during cholangitis in liver transplantation patients | Funda Ulu ztrk | ![]() |
![]() |
|||
P-212 | Transplanting Resectable Hepatocellular Carcinoma An Once for All Treatment Modality | MA Ka Wing | ![]() |
![]() |
|||
P-215 | Development of Cisplatin-Loaded Poly (ethylene glycol) and Gelatin-Based Hydrogels for Transarterial Chemoembolization in a Mouse Model of Orthotopic Liver Cancer | XINXIANG YANG | ![]() |
![]() |
|||
P-216 | The Surgical Outcome of Salvage Living Donor Liver Transplantation for Hepatocellular Carcinoma is Dependent on The Learning Curve; A Comparative Study with Propensity Score Analysis. | Shih-Ho Wang | ![]() |
![]() |
|||
P-217 | De novo Malignancies in 1639 consecutive Living Donor Liver Transplant Recipients | Anisha Tiwari | ![]() |
![]() |
|||
P-218 | A Multicenter Study to Assess the Incidence of Hepatocellular Carcinoma Recurrence after Liver Transplantation in Patients Treated with Direct-Acting Antivirals for Chronic Hepatitis C | Andre Gorgen | ![]() |
![]() |
|||
P-219 | Alpha-fetoprotein dynamics in the waiting list as a biomarker of hepatocellular carcinoma recurrence and mortality after liver transplant | Andre Gorgen | ![]() |
![]() |
|||
P-222 | Management and outcome of HCC recurrence after living donor liver transplantation according to expanded criteria regardless of size and number | RAHUL ROY | ![]() |
![]() |
|||
P-225 | 99mTechnetium-Mebrofenin Hepatobiliary Scintigraphy predicts portal hypertension in Child-Pugh A cirrhosis. | Bart Bracke | ![]() |
![]() |
|||
P-226 | Downstaging in cirrhotic and non-cirrhotic patients with multinodular hepatocellular carcinoma exceeding Milan criteria. | Annelotte Broekhoven | ![]() |
![]() |
|||
P-227 | Excellent Outcomes for Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma Treated with Neoadjuvant Therapy Comparable to Locally Advanced Hilar Cholangiocarcinoma: a Single Center Experience | Keri Lunsford | ![]() |
![]() |
|||
P-228 | Impact of Alpha-Fetoprotein Progression Slope on Cancer-Specific Mortality after Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients within Milan Criteria | Franck Nounamo | ![]() |
![]() |
|||
P-229 | Single nucleotide polymorphisms of CXCL9 (rs10336) and CXCL10 (rs3921) are not associated with hepatocellular carcinoma in alcoholic liver disease | Ana Ostojic | ![]() |
![]() |
|||
P-230 | Factors Affecting Recurrence and Survival after Liver Transplantation for Hepatocellular Carcinoma | Can Karaca | ![]() |
![]() |
|||
P-232 | Classical type and High Degree of Tumor Necrosis are Associated with Early Recurrence after Liver Transplantation for Combined Hepatocellular Carcinoma-cholangiocarcinoma | Woong Ki Park | ![]() |
![]() |
|||
P-234 | Complete pathological necrosis of hepatocellular carcinoma is determinant of the best cancer specific survival after liver transplantation, what are the pre-transplant predictors? | Chih-Che Lin | ![]() |
![]() |
|||
P-235 | Neutrophil to lymphocyte ratio lead to poor prognosis of hepatocellular carcinoma after liver transplantation through regulation of systemic cancer- and immune- related factors | Chih-Che Lin | ![]() |
![]() |
|||
P-236 | Risk for infection and non-infection related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014 | Martina Taborelli | ![]() |
![]() |
|||
P-240 | Liver transplant post neoadjuvant chemo-radiotherapy for hilar cholangiocarcinoma: a technical challenge but not a higher risk transplant | Barbara Fiore | ![]() |
![]() |
|||
P-242 | Living Donor Re-Transplantation for Repeated Acute Liver Failure | Volkan Ince | ![]() |
![]() |
|||
P-243 | Acute-on-chronic liver failure (ALCF) and Liver transplantation | Lucas Nacif | ![]() |
![]() |
|||
P-244 | Combined Liver Transplantation and Sleeve Gastrectomy for End- Stage Liver Disease in a Morbid Obese Patient. First Case Report Mexico | Mario Vilatoba | ![]() |
![]() |
|||
P-246 | Hyponatremia is Associated with Lower risk of PVT in Liver Transplant Candidates Independent of Liver Disease Severity. | Dmitri Bezinover | ![]() |
![]() |
|||
P-247 | Evaluation of TEG6s thromboelastography device in patients undergoing liver transplantation | Lasitha Abeysundara | ![]() |
![]() |
|||
P-248 | Thrombocytopenia after liver transplantation predictors of delayed recovery and its impact on outcome after liver transplantation | Akila Rajakumar | ![]() |
![]() |
|||
P-249 | Early Extubation Post Liver Transplantation: A single centres experience of an early extubation initiative | Ravi Bhatia | ![]() |
![]() |
|||
P-250 | Systolic anterior motion of mitral valve after reperfusion in liver transplantation | Uzung Yoon | ![]() |
![]() |
|||
P-251 | Pain Interventions For Organ Transplant Patients Undergoing Incisional Hernia Repair - Is Epidural or TAP Block A Better Option? | Samantha Yeap | ![]() |
![]() |
|||
P-254 | Exchange autotransfusion for a rapid correction ofhyperkalemia during liver transplantation | Uzung Yoon | ![]() |
![]() |
|||
P-255 | Preoperative Glycosylated haemoglobin(HbA1c) And Postoperative Morbidity And Mortality In Liver Transplant Patients: A Retrospective Study | MOHD QURRAM PARVEEZ | ![]() |
![]() |
|||
P-258 | Acute Heart Failure After Orthotopic Liver Transplantation | Sonal Sharma | ![]() |
![]() |
|||
P-260 | Successful LDLT in a case of mean pulmonary arterial pressure of 52 mmHg | Yang Won Nah | ![]() |
![]() |
|||
P-261 | Comparison of mixed venous oxygen saturation and central venous oxygen saturation in patients undergoing living donor liver transplantation | Hyun-Su Ri | ![]() |
![]() |
|||
P-262 | A Tense Situation and a Sticky End; Primary graft failure of an orthotopic liver transplant following cardiac arrest caused by mediastinal shift with dual, ipsilateral pathology: Mucus plug and pneumothorax | Vivienne Hannon | ![]() |
![]() |
|||
P-264 | Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation | King-Wah Chiu | ![]() |
![]() |
|||
P-265 | Relevance of steatosis in the regulation of cortisol levels in livers subjected to hepatic surgery | Esther Bujaldon | ![]() |
![]() |
|||
P-272 | Post-Reperfusion Bile pH and Glucose in Deceased donor Liver Transplant | Rohit Gaurav | ![]() |
![]() |
|||
P-273 | Novel self-assembling nanoparticle from irinotecan shows high anti-tumor efficacy in pancreatic cancer | Linshi Zhang | ![]() |
![]() |
|||
P-278 | FK506 Accelerates CoCl2 - induced Cytotoxicity via ER Stress Pathway in HepG2 Cells | Sang Young Chung | ![]() |
![]() |
|||
P-280 | LRP12 is associated with malignancies in liver cancer | Yingcai Yan | ![]() |
![]() |
|||
P-281 | Proliferation related EMT pathway induces the resistance of pancreatic cancer to gemcitabine | Jiarong Zhou | ![]() |
![]() |
|||
P-286 | Mechanism of FK506 induced TNF Related Apoptosis in Jurkat T Cells | Soo Jin Na Choi | ![]() |
![]() |
|||
P-295 | Recurrent hepatitis C antiviral treatment a real life study at a Brazilian transplant unit | Leticia Pisoni Zanaga | ![]() |
![]() |
|||
P-298 | Treatment Nave Hepatitis C Cirrhosis; Selected Scoring Systems and Survival in a Prison Population | Patrick Naeger | ![]() |
![]() |
|||
P-300 | The study of virological and immunologic factors of the progression of chronic viral hepatitis Delta in the Kazakh population | Bibigul Ilyassova | ![]() |
![]() |
|||
P-302 | First type 2 DCD human liver graft transplanted after normothermic machine perfusion. The improvement that leads to transplantation | Mihai-Calin Pavel | ![]() |
![]() |
|||
P-305 | Release of hyaluronan fragments during ex vivo perfusion of human liver | Caterina Lonati | ![]() |
![]() |
|||
P-308 | Age and area of study does not influence undergraduates opinions and awareness about organ donation | Eduardo Riccetto | ![]() |
![]() |
|||
P-310 | Donor Hypernatremia is not Associated with Primary Graft Dysfunction in Orthotopic Liver Tansplantation | Carlos Florez-Zorrilla | ![]() |
![]() |
|||
P-312 | Evolution and impact of obesity in patients on the liver transplant waiting list. | mathilde favre | ![]() |
![]() |
|||
P-315 | Is body mass index as a predictor of hepatic steatosis in living liver donors? | Birkan Bozkurt | ![]() |
![]() |
|||
P-318 | Changing hepatic grafts allocation, from chronological order to MELD based: repercussion upon the panel of aetiologies and on waiting-list mortality in a South-eastern Brazilian Centre | Agnaldo Soares Lima | ![]() |
![]() |
|||
P-319 | Selection criteria and prognostic factors for Liver Transplantation | Lucas Nacif | ![]() |
![]() |
|||
P-325 | ABO-incompatible living donor liver transplantation using a desensitizing protocol without local graft infusion therapy and splenectomy | Tae Beom Lee | ![]() |
![]() |
|||
P-329 | HEPATIC HEMODYNAMIC AFTER RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION WITH MIDDLE HEPATIC VEIN | Oleg Kotenko | ![]() |
![]() |
|||
P-332 | Randomized trial of Polytetrafluoroethylene(PTFE) vs. Native Recipient Portal Vein(RPV) for graft neo-MHV reconstruction in Right lobe Living Donor Liver Transplantation (LDLT) | MADHU SRINIVASAN DURARIRAJ | ![]() |
![]() |
|||
P-335 | Is Pre-Operative Biliary Imaging Mandatory in all Living Liver Donor Assessment? A Prospective Study | Noushif Medappil | ![]() |
![]() |
|||
P-338 | Application of portal pressure during adult living donor liver transplantation | Ting Lung Lin | ![]() |
![]() |
|||
P-339 | Laparoscopic-Hand Assisted Living Donor Right Hepatectomy: Case Series of a Single Center in USA | Paulo Martins | ![]() |
![]() |
|||
P-342 | Comparison of Hemoglobin levels via measured with pulse co-oximeter and with laboratory test during living donor hepatectomy | Yusuf Ziya Colak | ![]() |
![]() |
|||
P-344 | Safety of living donors in liver transplantation in a low volume transplant center | Seong Hwan Chang | ![]() |
![]() |
|||
P-346 | Modified venous patch Method for venous reconstruction in Liver Transplantation using right robe | Yoshihito Kotera | ![]() |
![]() |
|||
P-347 | Extraanatomic arterial reconstruction using great saphenous vein | Yangseok Koh | ![]() |
![]() |
|||
P-348 | ABO incompatible living donor liver transplantation for huge hepatomegaly due to polycystic liver disease | JE HO RYU | ![]() |
![]() |
|||
P-354 | Perioperative Anesthetic Management for Liver Transplantation in Child with Unrepaired Large Secundum Atrial Septal Defect (ASD) | Dritan Prifti | ![]() |
![]() |
|||
P-356 | Abernethy Syndrome Presenting with Hepatopulmonary Syndrome, Hematuria and Multiple FNHs | Rasim Farajov | ![]() |
![]() |
|||
P-358 | CD ratio may predict tacrolimus metabolism profile after Pediatric Liver Transplantation | Joel Stefani | ![]() |
![]() |
|||
P-360 | Reduced Size Living donor Left Lateral Graft Transplantation in an Infant with Biliary Atresia Splenic Malformation Syndrome and abdominal situs inversus | Meltem Bingol-Kologlu | ![]() |
![]() |
|||
P-363 | Health-related quality of life and psychosocial parameters in patients awaiting liver transplantation surgery: a service evaluation at the Royal Free Hospital | Clare Morkane | ![]() |
![]() |
|||
P-367 | Early biliary complications after different methods of end-to-end biliary anastomosis in liver transplant recipients | Agnieszka Józwik | ![]() |
![]() |
|||
P-370 | Liver transient elastography following liver transplantation | Lucas Nacif | ![]() |
![]() |
|||
P-371 | Comprehensive validation of different clinical prediction models on short- and long-term outcome following orthotopic liver transplantation | joerg boecker | ![]() |
![]() |
|||
P-374 | Hepaticojejunostomy for Benign Disease: Long-Term Stricture Rate and Management | JJ Klein | ![]() |
![]() |
|||
P-376 | Compromise between hepatectomy time and blood transfusion after liver transplantation: impact on 90-days mortality. | Mathieu GONOT-GASCHARD | ![]() |
![]() |
|||
P-378 | Good long term outcome with low recurrence rate in patients with Primary Sclerosing Cholangitis undergoing living donor liver transplantation | Sanjiv Saigal | ![]() |
![]() |
|||
P-379 | Anastomotic bilio-biliary strictures after adult liver transplantation: a retrospective study over 25 years in a single center | Jerome Dumortier | ![]() |
![]() |
|||
P-382 | Smoking until liver transplantation is a risk factor for anastomotic biliary stricture in duct to duct biliary reconstruction in the Meld Era. | Ferrandis charlotte | ![]() |
![]() |
|||
P-385 | Clinical Course of Hepatic Artery Thrombosis after Living Donor Liver Transplantation using Right Lobe | Yumi Kim | ![]() |
![]() |
|||
P-386 | Evaluation of Sleep Disorders with different Methods in Cirrhotics waiting on the liver transplantation list : EEG, Polysomnography, PSQI,ESS | GENCO GENDAL | ![]() |
![]() |
|||
P-387 | Simultaneous Cardiothoracic Surgery and Liver Transplantation: A Viable Option | Christine Myo | ![]() |
![]() |
|||
P-388 | Risk factors of graft loss in early allograft dysfunction following liver transplantation | Qinfen Xie | ![]() |
![]() |
|||
P-391 | ABO incompitable liver transplantation,case report and review of the literature. | Deng Feiwen | ![]() |
![]() |
|||
P-393 | The experience of everolimus combined with tacrolimus in living donor liver transplantation | Sheng-Chih Kuo | ![]() |
![]() |
|||
P-395 | Central Pontine Myelinolysis after Liver Transplantation | Angela Strother | ![]() |
![]() |
|||
P-396 | Primary Graft Dysfunction D-MELD and MEAF scores as accurate predictors of outcome | Joăo Cardoso | ![]() |
![]() |
|||
P-398 | Severe leukopenia in liver transplant recipient: the role of ive splenic artery embolization | Marina Premuzic | ![]() |
![]() |
|||
P-400 | Duct to Duct Biliary Reconstruction in Pediatric Split Liver Transplantation | Rasim Farajov | ![]() |
![]() |
|||
P-402 | EARLY CARDIOVASCULAR EVENTS IN PATIENTS WITH LIVER TRANSPLANT: INCIDENCE, ETHIOLOGY, RISK FACTORS AND OUTCOME | Ana Arias | ![]() |
![]() |
|||
P-405 | Metabolic syndrome after liver transplantation: long-term follow up in a prospective cohort | Chiara Becchetti | ![]() |
![]() |
|||
P-406 | Does donor liver weight influences liver enzymatic determination immediately after liver transplantation? | Marco Pellicciaro | ![]() |
![]() |
|||
P-408 | Outcomes of Deceased Donor Liver Transplantation using Marginal Graft in Single Asian Center | Dong-Sik Kim | ![]() |
![]() |
|||
P-410 | Atypical presentation of zygomycosis in the early post-liver transplant period under fungal prophylaxis | Saliba Faouzi | ![]() |
![]() |
|||
P-413 | The experiences of liver transplantation in small volume center | Jeongwoo Lee | ![]() |
![]() |
|||
P-415 | Elderly Donor and Gender Impact on Cumulative Survival Rates of Liver Graft Recipient in 20 years of Experience in Santiago de Compostela (Spain). | Rita Fernandez Garda | ![]() |
![]() |
|||
P-417 | Simultaneous Multiple Organ Transplantation including liver Grafts | Chul Soo Ahn | ![]() |
![]() |
|||
P-419 | Emergency liver transplantation strategy for vascular hilar injuries associated with laparoscopic cholecystectomy | Aniroodh Shankar | ![]() |
![]() |
|||
P-421 | Portal vein thrombosis in adult patients with cirrhosis: outcomes of liver transplantation | Daniele Dondossola | ![]() |
![]() |
|||
P-422 | Long-term outcome of dilatation and stenting of anastomotic and non-anastomotic biliary strictures after liver transplantation | Bart van Hoek | ![]() |
![]() |
|||
P-424 | Arterial Anastomotic Bleeding and Median Arcuate Ligament Syndrome Inducing Hepatic Artery Thrombosis and Salvage Liver Transplantation | Sun Xiaodong | ![]() |
![]() |
|||
P-425 | Utilization of Extrocorporeal Membrane Oxygenation for a Severe Cardiocirculatory Dysfunction Recipient in Liver Transplantation | Fan Zhongqi | ![]() |
![]() |
|||
P-427 | Surgical Porto-caval Shunt and liver transplantation: systematic review | Lucas Nacif | ![]() |
![]() |
|||
P-432 | A case of jaundice with unknown reason after orthotropic liver transplantation | AIHUA YAO | ![]() |
![]() |
|||
P-433 | Single center experience of liver transplant for hepatocellular carcinoma with liver donation after citizens death in China | Chen Huanwei | ![]() |
![]() |
|||
P-435 | Manual Computed Tomography Liver Volumetry: Can it be Done Faster? | Kemal Murat Haberal | ![]() |
![]() |
|||
P-436 | Portal venous flow alterations in the hepatic artery thrombosis following liver transplant | Sehnaz Tezcan | ![]() |
![]() |
|||
P-438 | Percutaneous transhepatic treatment of biliary complications in pediatric patients following living donor liver transplantation | An Ni Lin | ![]() |
![]() |
|||
P-439 | Volumetric Reevaluation of Liver Left Lateral Segment Donors, which had Previously Been Incompatible with Intraoperative Weight Findings | Kemal Murat Haberal | ![]() |
![]() |
|||
P-446 | Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation | Jian Chen | ![]() |
![]() |
|||
P-450 | Is liver transplantation for hepatocellular carcinoma with portal vein invasion oncologically justified? A propensity-score matched analysis with hepatic resection. | Albert Chan | ![]() |
![]() |
|||
P-452 | TGFBI promotes the pancreatic cancer cells metastasis to liver through the inflammatory-related epithelial to mesenchymal transition | Huilin Zheng | ![]() |
![]() |
|||
P-462 | Long-Term Survival of a Patient with Urothelial and Liver Cancers Managed by Tumor Resection, Transplantation and Adenovirus-mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration | Zhaobo Liu | ![]() |
![]() |
|||
P-465 | Survival Outcomes of Liver Transplantation for Hepatocellular Carcinoma in patients with normal, high and very high preoperative AFP levels | Wong Hoi She | ![]() |
![]() |
|||
P-466 | Three-years survival in liver transplant recipients with HCC history | Paria Mahboub | ![]() |
![]() |
|||
P-470 | Liver Transplantation As A valuable Treatment For huge Hepatocellular Carcinoma Beyond The Hangzhou Criteria: A Case Report | Qinfen Xie | ![]() |
![]() |
May 23 – 26, 2018 in Lisbon, Portugal. Lisboa
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|